Effects of acute glucocorticoid blockade on metabolic dysfunction in patients with Type 2 diabetes with and without fatty liver

To investigate the potential of therapies which reduce glucocorticoid action in patients with Type 2 diabetes we performed a randomized, double-blinded, placebo-controlled crossover study of acute glucocorticoid blockade, using the glucocorticoid receptor antagonist RU38486 (mifepristone) and cortis...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Macfarlane, D. P., Raubenheimer, P. J., Preston, T., Gray, C. D., Bastin, M. E., Marshall, I., Iredale, J. P., Andrew, R., Walker, B. R.
Format: Artigo
Jezik:Inglês
Izdano: American Physiological Society 2014
Teme:
Hormones and Signaling
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4187063/
https://ncbi.nlm.nih.gov/pubmed/25104497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpgi.00030.2014
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items